Cargando…

A Novel CRISPR/Cas9 Screening Potential Index for Prognostic and Immunological Prediction in Low-Grade Glioma

Glioma is a malignancy with the highest mortality in central nervous system disorders. Here, we implemented the computational tools based on CRISPR/Cas9 to predict the clinical outcomes and biological characteristics of low-grade glioma (LGG). The transcriptional expression profiles and clinical phe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiangpan, Xiong, Kewei, Bi, Dong, Zhao, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109250/ https://www.ncbi.nlm.nih.gov/pubmed/35586564 http://dx.doi.org/10.3389/fgene.2022.839884

Ejemplares similares

The Prognostic and Immunological Value of Guanylate-Binding Proteins in Lower-Grade Glioma: Potential Markers or Not?
por: Liu, Zhuang, et al.
Publicado: (2021)

Redox-associated messenger RNAs identify novel prognostic values and influence the tumor immune microenvironment of lung adenocarcinoma
por: Zhao, Chen, et al.
Publicado: (2023)

Parallel CRISPR-Cas9 screens clarify impacts of p53 on screen performance
por: Bowden, Anne Ramsay, et al.
Publicado: (2020)

A new age in functional genomics using CRISPR/Cas9 in arrayed library screening
por: Agrotis, Alexander, et al.
Publicado: (2015)

Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
por: Duan, Li, et al.
Publicado: (2021)

Establishment of an Endocytosis-Related Prognostic Signature for Patients With Low-Grade Glioma
por: Wang, Dawei, et al.
Publicado: (2021)

Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma
por: Zhang, Mingwei, et al.
Publicado: (2020)

CRISPR-Cas9 knockout screen identifies novel treatment targets in childhood high-grade glioma
por: Wenger, Anna, et al.
Publicado: (2023)

Adapting CRISPR/Cas9 System for Targeting Mitochondrial Genome
por: Hussain, Syed-Rehan A., et al.
Publicado: (2021)

CRISPR-cas9 screening identified lethal genes enriched in Hippo kinase pathway and of predictive significance in primary low-grade glioma
por: Mijiti, Maimaitili, et al.
Publicado: (2023)

Prognostic Roles of Central Carbon Metabolism–Associated Genes in Patients With Low-Grade Glioma
por: Wang, Li, et al.
Publicado: (2019)

Early “reduction to practice” of the CRISPR–Cas9 invention in eukaryotic cells
por: Aquino-Jarquin, Guillermo
Publicado: (2022)

TUBA1C is a Prognostic Marker in Low-grade Glioma and Correlates with Immune Cell Infiltration in the Tumor Microenvironment
por: Zhu, Hua, et al.
Publicado: (2021)

Prognostic Model and Nomogram Construction and Validation With an Autophagy-Related Gene Signature in Low-Grade Gliomas
por: Li, Xinrui, et al.
Publicado: (2022)

CRISPR/Cas9 Application for Gene Copy Fate Survey of Polyploid Vertebrates
por: Yin, Fanqian, et al.
Publicado: (2018)

Machine learning in the estimation of CRISPR-Cas9 cleavage sites for plant system
por: Das, Jutan, et al.
Publicado: (2023)

The Prognostic Value and Immunological Role of STEAP1 in Pan-Cancer: A Result of Data-Based Analysis
por: Zhao, Chen, et al.
Publicado: (2022)

A Novel Inflammatory lncRNAs Prognostic Signature for Predicting the Prognosis of Low-Grade Glioma Patients
por: Xiang, Zijin, et al.
Publicado: (2021)

The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma
por: Han, Yunhe, et al.
Publicado: (2021)

Recent Advances in the Application of CRISPR/Cas9 Gene Editing System in Poultry Species
por: Khwatenge, Collins N., et al.
Publicado: (2021)

Advancements and prospects of CRISPR/Cas9 technologies for abiotic and biotic stresses in sugar beet
por: Misra, Varucha, et al.
Publicado: (2023)

Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9
por: Brunetti, Lorenzo, et al.
Publicado: (2018)

Endogenous Protein Tagging in Human Induced Pluripotent Stem Cells Using CRISPR/Cas9
por: Haupt, Amanda, et al.
Publicado: (2018)

A Novel Hybrid CNN-SVR for CRISPR/Cas9 Guide RNA Activity Prediction
por: Zhang, Guishan, et al.
Publicado: (2020)

Quality Control Strategy for CRISPR-Cas9-Based Gene Editing Complicated by a Pseudogene
por: Hanss, Zoé, et al.
Publicado: (2020)

First Report on CRISPR/Cas9-Based Genome Editing in the Destructive Invasive Pest Tuta Absoluta (Meyrick) (Lepidoptera: Gelechiidae)
por: Ji, Shun-Xia, et al.
Publicado: (2022)

Arachidonate lipoxygenases 5 is a novel prognostic biomarker and correlates with high tumor immune infiltration in low-grade glioma
por: Pan, Rui-han, et al.
Publicado: (2023)

Advanced In vivo Use of CRISPR/Cas9 and Anti-sense DNA Inhibition for Gene Manipulation in the Brain
por: Walters, Brandon J., et al.
Publicado: (2016)

Efficient Production and Identification of CRISPR/Cas9-generated Gene Knockouts in the Model System Danio rerio
por: Sorlien, Erin L., et al.
Publicado: (2018)

CRISPR/Cas9 Mutagenesis and Expression of Dominant Mutant Transgenes as Functional Genomic Approaches in Parasitic Nematodes
por: Lok, James B.
Publicado: (2019)

Precise and Rapid Validation of Candidate Gene by Allele Specific Knockout With CRISPR/Cas9 in Wild Mice
por: Chao, Tianzhu, et al.
Publicado: (2019)

QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii
por: Shen, Bang, et al.
Publicado: (2017)

Applications of CRISPR-Cas9 for advancing precision medicine in oncology: from target discovery to disease modeling
por: Ravichandran, Mirunalini, et al.
Publicado: (2023)

Multiplex CRISPR/Cas screen in regenerating haploid limbs of chimeric Axolotls
por: Sanor, Lucas D, et al.
Publicado: (2020)

Commentary: RNA editing with CRISPR-Cas13
por: Matsoukas, Ianis G.
Publicado: (2018)

Immunological and prognostic analysis of PSENEN in low-grade gliomas: An immune infiltration-related prognostic biomarker
por: Chen, Kaijie, et al.
Publicado: (2022)

Establishment and Validation of a 5 m6A RNA Methylation Regulatory Gene Prognostic Model in Low-Grade Glioma
por: Bai, Zhiqun, et al.
Publicado: (2022)

From Bioengineering to CRISPR/Cas9 – A Personal Retrospective of 20 Years of Research in Programmable Genome Targeting
por: Jeltsch, Albert
Publicado: (2018)

Efficient and Precise CRISPR/Cas9-Mediated MECP2 Modifications in Human-Induced Pluripotent Stem Cells
por: Le, Thi Thanh Huong, et al.
Publicado: (2019)

CRISPR/Cas9-Mediated α-ENaC Knockout in a Murine Pancreatic β-Cell Line
por: Zhang, Xue, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_akaocc8sicpgvbflrt8dj7uqek